Literature DB >> 7810973

[Rectovaginal fistulas in adults].

P Frileux1, A Berger, F Zinzindohoue, P H Cugnenc, R Parc.   

Abstract

Recto-vaginal fistulas have multiple causes and a wide range of clinical and anatomical features. Simple fistulas, defined by a low situation, a traumatic origin, and a small size are accessible to simple means of cure. They can be operated from a vaginal approach, with conversion into a third degree perineal tear followed by repair of the perineal body, and the anal canal; they can be managed from a transanal approach, using endorectal flap advancement technique. Complex fistulas, defined by the etiology (IBD, radiation enteritis, cancer, postoperative), a high situation, or a large size, require larger and more sophisticated operations such as a combined abdomino-perineal approach or a muscle flap technique. Among the numerous techniques described for the cure of recto-vaginal fistulas, the authors emphasize those currently used by the most experienced teams of colo-rectal or gynecological surgeons.

Entities:  

Mesh:

Year:  1994        PMID: 7810973

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  4 in total

1.  Graciloplasty for recurrent recto-neovaginal fistula in a male-to-female transsexual.

Authors:  D F Altomare; I Scalera; C Bettocchi; M Di Lena
Journal:  Tech Coloproctol       Date:  2012-08-10       Impact factor: 3.781

2.  Management of genital fistulas in patients with cervical cancer.

Authors:  C Emmert; U Köhler
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

3.  Recent advances in the management of radiation colitis.

Authors:  Jannis Kountouras; Christos Zavos
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

4.  Surgical mistake causing an high recto-vaginal fistula. A case report with combined surgical and endoscopic approach: therapeutic considerations.

Authors:  Michele Danzi; Fabozzi Massimiliano; Reggio Stefano; Pannullo Mario; Amato Bruno; Grimaldi Luciano
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.